Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Froelich

Showing results (961-970 of 983) with videos related to

Pageof 99
Sort By:
Molecular Neurodegeneration|March 29, 2022
Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's diseasePieter Jelle Visser, Lianne M Reus, Johan Gobom, et al.
The Journal of Prevention of Alzheimer'S Disease|January 22, 2026
Clinical, imaging and blood biomarker outcomes in a Phase 3 clinical trial of tau aggregation inhibitor hydromethylthionine mesylate in mild cognitive impairment and mild to moderate dementia due to Alzheimer's diseaseClaude M Wischik, Richard Stefanacci, Peter Bentham, et al.
Neuro-Chirurgie|March 5, 2021
Security and reliability of CUSTOMBONE cranioplasties: A prospective multicentric studyA Amelot, A Nataloni, P François, et al.
Nature Aging|April 28, 2023
ADAMANT: a placebo-controlled randomized phase 2 study of AADvac1, an active immunotherapy against pathological tau in Alzheimer's diseasePetr Novak, Branislav Kovacech, Stanislav Katina, et al.
Cell Reports. Medicine|August 9, 2025
Combined MEK and PARP inhibition enhances radiation response in rectal cancerQiyun Xiao, Julian E Riedesser, Theresa Mulholland, et al.
Frontiers in Neurology|November 4, 2015
The Central Biobank and Virtual Biobank of BIOMARKAPD: A Resource for Studies on Neurodegenerative DiseasesBabette L R Reijs, Charlotte E Teunissen, Nikolai Goncharenko, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 9, 2022
European consensus for the diagnosis of MCI and mild dementia: Preparatory phaseCristina Festari, Federico Massa, Matteo Cotta Ramusino, et al.
The Lancet. Neurology|February 16, 2024
European intersocietal recommendations for the biomarker-based diagnosis of neurocognitive disordersGiovanni B Frisoni, Cristina Festari, Federico Massa, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 9, 2026
Revising the ABIDE MCI to dementia prediction model for automated cerebrospinal fluid assaysPieter J van der Veere, Argonde C van Harten, Ingrid S van Maurik, et al.
JAMA Neurology|November 1, 2024
Alzheimer Disease as a Clinical-Biological Construct-An International Working Group RecommendationBruno Dubois, Nicolas Villain, Lon Schneider, et al.
Pageof 99

Showing results (961-970 of 983) with videos related to

Sort By:
Pageof 99
Molecular Neurodegeneration|March 29, 2022
Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's diseasePieter Jelle Visser, Lianne M Reus, Johan Gobom, et al.
The Journal of Prevention of Alzheimer'S Disease|January 22, 2026
Clinical, imaging and blood biomarker outcomes in a Phase 3 clinical trial of tau aggregation inhibitor hydromethylthionine mesylate in mild cognitive impairment and mild to moderate dementia due to Alzheimer's diseaseClaude M Wischik, Richard Stefanacci, Peter Bentham, et al.
Neuro-Chirurgie|March 5, 2021
Security and reliability of CUSTOMBONE cranioplasties: A prospective multicentric studyA Amelot, A Nataloni, P François, et al.
Nature Aging|April 28, 2023
ADAMANT: a placebo-controlled randomized phase 2 study of AADvac1, an active immunotherapy against pathological tau in Alzheimer's diseasePetr Novak, Branislav Kovacech, Stanislav Katina, et al.
Cell Reports. Medicine|August 9, 2025
Combined MEK and PARP inhibition enhances radiation response in rectal cancerQiyun Xiao, Julian E Riedesser, Theresa Mulholland, et al.
Frontiers in Neurology|November 4, 2015
The Central Biobank and Virtual Biobank of BIOMARKAPD: A Resource for Studies on Neurodegenerative DiseasesBabette L R Reijs, Charlotte E Teunissen, Nikolai Goncharenko, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 9, 2022
European consensus for the diagnosis of MCI and mild dementia: Preparatory phaseCristina Festari, Federico Massa, Matteo Cotta Ramusino, et al.
The Lancet. Neurology|February 16, 2024
European intersocietal recommendations for the biomarker-based diagnosis of neurocognitive disordersGiovanni B Frisoni, Cristina Festari, Federico Massa, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 9, 2026
Revising the ABIDE MCI to dementia prediction model for automated cerebrospinal fluid assaysPieter J van der Veere, Argonde C van Harten, Ingrid S van Maurik, et al.
JAMA Neurology|November 1, 2024
Alzheimer Disease as a Clinical-Biological Construct-An International Working Group RecommendationBruno Dubois, Nicolas Villain, Lon Schneider, et al.
Pageof 99